Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Idiopathic Juvenile Osteoporosis
NCT00001720Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Mar 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in idiopathic juvenile osteoporosis (IJO) comparing Alendronate with Placebo (2 arms). Primary endpoint: Bone Mineral Density at 12 months. Started Mar 1998; status: completed.
02
Drugs
alendronate
03
Conditions
idiopathic juvenile osteoporosis (IJO)
Beyond the preview
Go deeper on NCT00001720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001720.